Developer docs
API playgroundTry for free, no card

Search company profiles

MDBriefCase

Full company profile

uuid000bz99

Namestring
MDBriefCase
Legal namestring
MDBriefCase
Websiteurl
mdbriefcase.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

MDBriefCase is a Toronto-based digital continuing medical education (CME/CPD) platform founded in 2004 that provides free, accredited on-demand courses to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East (notably Saudi Arabia), the UK, and Europe. The core product is a web-based learning management system delivering content through eCME modules, video lectures, expert briefs, microlearnings (5–20 minutes), interactive quizzes, animations, webinars, and downloadable resources across therapeutic areas including cardiovascular disease, diabetes, mental health, dermatology, menopause, oncology, and respiratory medicine.

The underlying technology is a multi-format LMS with regional content adaptation and integration into national accreditation systems: Mainpro+ via the College of Family Physicians of Canada (CFPC), Canadian Council on Continuing Education in Pharmacy (CCCEP) accreditation for pharmacists, and parallel accreditation via RACGP (Australia), RCGP (UK), and SCFHS (Saudi Arabia). Content is co-developed and peer-reviewed with 30+ medical associations and universities (Queens University, University of Alberta, University of Manitoba, Sunnybrook Health Sciences Centre, Canadian Thoracic Society, Obesity Canada, MHCC, among others), and delivered in English and French. The platform operates a sub-brand ecosystem including RxBriefCase (pharmacy), RxNow (real-time pharmacy updates), Postcall (weekly newsletter, 15,000+ Canadian clinician subscribers), and OncologyEducation.

MDBriefCase operates a freemium/end-user-free business model. All course content is provided at no cost to clinicians; revenue is generated primarily through unrestricted educational grants and sponsorships from pharmaceutical and medical device companies that fund branded or therapeutic-area CME modules, with secondary revenue from advertising placements on the Postcall newsletter. The company is a wholly-owned subsidiary of Think Research, a strategic operating company that also owns Pharmapod, OncologyEducation, and related clinical-decision-support assets. Headcount, revenue figures, and detailed financial disclosures are not publicly available.

Short descriptiontext

MDBriefCase is a Toronto-headquartered digital CME/CPD platform, founded in 2004 and a subsidiary of Think Research, that delivers free accredited continuing education courses, webinars, and a weekly newsletter to 285,000+ physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
continuing medical education, CME/CPD platforms, accredited medical courses, healthcare professional training, pharmacy continuing education
Industry4 codes
PRIMARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
SECONDARYEDAAALAC
Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)
Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)
SECONDARYEDAGABAG
Medicine & Allied Health (Clinical)
Education/Educational Publishing & Learning Content/Higher Education Textbooks & Courseware
SECONDARYEDAAAPAA
Healthcare & Life Sciences
Education/Adult & Continuing Education/Industry-Specific Training (Healthcare, Tech, etc.)
NAICS code2 codes
  • Newspaper, Periodical, Book, and Directory Publishers5131
  • Software Publishers5132
SIC code1 code
  • Miscellaneous Publishing2741
Product category
Continuing Medical Education
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Educational Grants
TypeFreemium
Description

The primary revenue model consists of unrestricted educational grants and sponsorships from pharmaceutical and medical device companies. These companies fund specific educational programs in exchange for having their products or therapeutic areas featured within accredited CME content.

mdbriefcase.com
2Advertising - Postcall Newsletter
TypeFreemium
Description

The Postcall newsletter monetizes its 15,000+ subscriber base through sponsored content placements from healthcare brands.

mdbriefcase.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Free access to all CME/CPD content
ModelFreemiumBilling cadencePay-as-you-go
Notes

Users access hundreds of hours of accredited medical education content at no cost. All courses, modules, microlearnings, and resources are free. Revenue is generated through pharmaceutical company sponsorships and educational grants that fund content development.

mdbriefcase.com
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Brand1 of 3 records shown
1RxBriefcase
Description

MDBriefCase's pharmacy-focused continuing education learning platform

mdbriefcase.com
+2 more records
Core offering1 text field

MDBriefCase operates a digital continuing medical education (CME/CPD) platform that delivers free, accredited on-demand courses, live webinars, microlearnings, expert briefs, and clinical updates to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe. Content is developed with more than 30 global medical partner institutions and accredited through Mainpro+/CFPC, CCCEP, RACGP, RCGP, and other regional bodies. Revenue is generated through unrestricted pharmaceutical educational grants and newsletter sponsorships rather than user fees.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 285,000+ healthcare professionals worldwide rely on MDBriefCase for continuing education
+2 more records
Product overview1 text field

MDBriefCase is a multi-platform continuing medical education ecosystem providing accredited CME/CPD courses for physicians, pharmacists, nurses, and allied healthcare professionals. The core MDBriefCase platform offers on-demand courses, live webinars, microlearning modules, expert briefs, and video content across 11+ therapeutic areas (cardiovascular, diabetes, mental health, dermatology, women's health, etc.). The ecosystem includes complementary sub-brands: Postcall (weekly medical newsletter for Canadian clinicians), RxBriefcase (pharmacy-specific learning), RxNow (real-time pharmacy updates), OncologyEducation (oncology education), and Pharmapod (pharmacy safety). Content is developed with 40+ global medical partners and is entirely free for users, with Mainpro+ and other regional accreditation.

Product and service5 records
1MDBriefCase CME/CPD Platform
CategoryContinuing Medical Education
Description

Core digital learning platform providing free accredited CME/CPD courses, live webinars, microlearning modules, expert briefs, video content, and downloadable resources across 11+ therapeutic areas (cardiovascular, diabetes, mental health, dermatology, oncology, respirology, paediatrics, etc.) for physicians, pharmacists, nurses, and allied health professionals in Canada, Australia, the Middle East, the UK, and Europe.

2RxBriefcase
CategoryPharmacy Continuing Education
Description

Pharmacy-focused continuing education platform offering accredited courses, CCCEP-accredited CE credits, and clinical updates specifically designed for pharmacists.

3Postcall Newsletter
CategoryMedical Newsletter / Continuing Education Content
Description

Weekly newsletter 'Canadian medicine's must-know newsletter' delivering high-yield medicine summaries, clinical insights, and medical news to 15,000+ Canadian clinicians, with sponsored content placements from healthcare brands.

4RxNow
CategoryPharmacy Continuing Education
Description

Real-time continuing education content and updates resource hub for pharmacists and healthcare professionals.

5HTA Workshop Series for Saudi Arabia
CategoryHealth Technology Assessment Training
Description

Multi-module health economics and pharmacoeconomics workshop program aligned with Saudi Food and Drug Authority (SFDA) requirements for health technology assessment submissions, targeting HTA professionals in Saudi Arabia.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Primary accreditation partner for Canadian family physicians. MDBriefCase courses are certified for Mainpro+ credits through CFPC and Quebec College of Family Physicians.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Accreditation partner for Australian general practitioners. Courses are adapted and certified for Australian CME requirements.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UK-based accreditation partner for continuing professional development for general practitioners.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partnership for medical education content development and review.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partnership for medical education content development.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partnership for medical education content development.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic hospital partnership for clinical content development and expert faculty.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Professional society partnership for respiratory and pulmonary medicine content.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership for obesity management and metabolic health educational content.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership for mental health education and awareness content.

11Saudi Food and Drug Authority (SFDA) / MOH
Strategic tierCoreTypeStrategic or Co-development Partner
Description

HTA training programs for Saudi Arabian market, aligned with SFDA requirements for health technology assessment submissions.

mdbriefcase.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Parent company providing clinical decision support tools and connected ecosystem including RxBriefCase, Pharmapod, and OncologyEducation.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

WebMD-owned Medscape is the largest global digital CME provider for physicians, offering free accredited continuing education funded by pharma sponsorship — the same freemium, grant-monetized model that MDBriefCase operates.

TypeDirect peer
Description

Clinical Care Options produces accredited CME/CE activities for physicians, pharmacists, and nurses funded by educational grants from pharma, overlapping directly with MDBriefCase's target audience and revenue model.

3HealthStream
TypeBroad incumbent
Description

HealthStream is a publicly traded healthcare workforce education and training company that addresses a related but broader enterprise compliance and clinical education market versus MDBriefCase's free, clinician-direct CME.

TypeBroad incumbent
Description

Wolters Kluwer's UpToDate is a clinical decision support and learning platform used by clinicians globally, adjacent to MDBriefCase's CME offering but broader in scope and primarily sold via institutional licenses rather than free, grant-funded CME.

TypeDirect peer
Description

Pri-Med provides free CME/CE for primary care clinicians through online and in-person channels, including pharma-supported programming — a directly comparable primary care-focused CME platform.

6ProCE
TypeDirect peer
Description

ProCE is an accredited provider of continuing pharmacy education, directly comparable to MDBriefCase's RxBriefcase subsidiary for pharmacist-targeted accredited CE.

7CE City
TypeDirect peer
Description

CE City provides accredited continuing education tracking and delivery for healthcare professionals, comparable to MDBriefCase's platform in serving the CE/CME credit accumulation workflow.

TypeDirect peer
Description

ACHL is an ACCME-accredited provider of pharma-funded CME/CE across multiple therapeutic areas, competing with MDBriefCase for the same clinician audiences and pharma sponsorships.

TypeBroad incumbent
Description

EBSCO's DynaMed is a clinician reference and decision-support tool that competes for the same clinician mindshare as MDBriefCase's expert briefs and CME content, with a broader portfolio and institutional sales model.

TypeBroad incumbent
Description

Haymarket Media's medical division produces pharma-funded medical education, journals, and CME, comparable to MDBriefCase in its grant-funded clinician education model but operating at significantly greater scale across multiple global brands.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MDBriefCase

Continuing Medical Educationmdbriefcase.com

MDBriefCase is a Toronto-headquartered digital CME/CPD platform, founded in 2004 and a subsidiary of Think Research, that delivers free accredited continuing education courses, webinars, and a weekly newsletter to 285,000+ physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe.

What MDBriefCase does

MDBriefCase is a Toronto-based digital continuing medical education (CME/CPD) platform founded in 2004 that provides free, accredited on-demand courses to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East (notably Saudi Arabia), the UK, and Europe. The core product is a web-based learning management system delivering content through eCME modules, video lectures, expert briefs, microlearnings (5–20 minutes), interactive quizzes, animations, webinars, and downloadable resources across therapeutic areas including cardiovascular disease, diabetes, mental health, dermatology, menopause, oncology, and respiratory medicine.

The underlying technology is a multi-format LMS with regional content adaptation and integration into national accreditation systems: Mainpro+ via the College of Family Physicians of Canada (CFPC), Canadian Council on Continuing Education in Pharmacy (CCCEP) accreditation for pharmacists, and parallel accreditation via RACGP (Australia), RCGP (UK), and SCFHS (Saudi Arabia). Content is co-developed and peer-reviewed with 30+ medical associations and universities (Queens University, University of Alberta, University of Manitoba, Sunnybrook Health Sciences Centre, Canadian Thoracic Society, Obesity Canada, MHCC, among others), and delivered in English and French. The platform operates a sub-brand ecosystem including RxBriefCase (pharmacy), RxNow (real-time pharmacy updates), Postcall (weekly newsletter, 15,000+ Canadian clinician subscribers), and OncologyEducation.

MDBriefCase operates a freemium/end-user-free business model. All course content is provided at no cost to clinicians; revenue is generated primarily through unrestricted educational grants and sponsorships from pharmaceutical and medical device companies that fund branded or therapeutic-area CME modules, with secondary revenue from advertising placements on the Postcall newsletter. The company is a wholly-owned subsidiary of Think Research, a strategic operating company that also owns Pharmapod, OncologyEducation, and related clinical-decision-support assets. Headcount, revenue figures, and detailed financial disclosures are not publicly available.

MDBriefCase firmographics

Firmographics
Name
MDBriefCase
Legal name
MDBriefCase
Website
https://mdbriefcase.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
MDBriefCase is a Toronto-headquartered digital CME/CPD platform, founded in 2004 and a subsidiary of Think Research, that delivers free accredited continuing education courses, webinars, and a weekly newsletter to 285,000+ physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe.
Ownership category
akta.pro rank

MDBriefCase industry classification

Industry
Product category
Continuing Medical Education
NAICS
Newspaper, Periodical, Book, and Directory Publishers (5131), Software Publishers (5132)
SIC
Miscellaneous Publishing (2741)
akta.pro industry
PRIMARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
SECONDARYEDAAALAC
Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)
Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)
SECONDARYEDAGABAG
Medicine & Allied Health (Clinical)
Education/Educational Publishing & Learning Content/Higher Education Textbooks & Courseware
SECONDARYEDAAAPAA
Healthcare & Life Sciences
Education/Adult & Continuing Education/Industry-Specific Training (Healthcare, Tech, etc.)

Keywords

  • Continuing medical education
  • CME/CPD platforms
  • Accredited medical courses
  • Healthcare professional training
  • Pharmacy continuing education

Where MDBriefCase is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Markets served

MDBriefCase business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Pharmaceutical Educational Grants: The primary revenue model consists of unrestricted educational grants and sponsorships from pharmaceutical and medical device companies. These companies fund specific educational programs in exchange for having their products or therapeutic areas featured within accredited CME content.
  2. Advertising - Postcall Newsletter: The Postcall newsletter monetizes its 15,000+ subscriber base through sponsored content placements from healthcare brands.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree access to all CME/CPD content

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

MDBriefCase product offering

Product offering

Core offering

MDBriefCase operates a digital continuing medical education (CME/CPD) platform that delivers free, accredited on-demand courses, live webinars, microlearnings, expert briefs, and clinical updates to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe. Content is developed with more than 30 global medical partner institutions and accredited through Mainpro+/CFPC, CCCEP, RACGP, RCGP, and other regional bodies. Revenue is generated through unrestricted pharmaceutical educational grants and newsletter sponsorships rather than user fees.

Product overview

MDBriefCase is a multi-platform continuing medical education ecosystem providing accredited CME/CPD courses for physicians, pharmacists, nurses, and allied healthcare professionals. The core MDBriefCase platform offers on-demand courses, live webinars, microlearning modules, expert briefs, and video content across 11+ therapeutic areas (cardiovascular, diabetes, mental health, dermatology, women's health, etc.). The ecosystem includes complementary sub-brands: Postcall (weekly medical newsletter for Canadian clinicians), RxBriefcase (pharmacy-specific learning), RxNow (real-time pharmacy updates), OncologyEducation (oncology education), and Pharmapod (pharmacy safety). Content is developed with 40+ global medical partners and is entirely free for users, with Mainpro+ and other regional accreditation.

Differentiator

Problem solved

Functional benefit

Brands

  • RxBriefcase: MDBriefCase's pharmacy-focused continuing education learning platform
  • Postcall
  • RxNow

Products and services

  • MDBriefCase CME/CPD Platform Core digital learning platform providing free accredited CME/CPD courses, live webinars, microlearning modules, expert briefs, video content, and downloadable resources across 11+ therapeutic areas (cardiovascular, diabetes, mental health, dermatology, oncology, respirology, paediatrics, etc.) for physicians, pharmacists, nurses, and allied health professionals in Canada, Australia, the Middle East, the UK, and Europe.
  • RxBriefcase Pharmacy-focused continuing education platform offering accredited courses, CCCEP-accredited CE credits, and clinical updates specifically designed for pharmacists.
  • Postcall Newsletter Weekly newsletter 'Canadian medicine's must-know newsletter' delivering high-yield medicine summaries, clinical insights, and medical news to 15,000+ Canadian clinicians, with sponsored content placements from healthcare brands.
  • RxNow Real-time continuing education content and updates resource hub for pharmacists and healthcare professionals.
  • HTA Workshop Series for Saudi Arabia Multi-module health economics and pharmacoeconomics workshop program aligned with Saudi Food and Drug Authority (SFDA) requirements for health technology assessment submissions, targeting HTA professionals in Saudi Arabia.

Quantifiable outcome

  • 285,000+ healthcare professionals worldwide rely on MDBriefCase for continuing education
  • +2 more outcomes

Companies that use MDBriefCase

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

MDBriefCase technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MDBriefCase partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and major.

  • College of Family Physicians of Canada (CFPC)coreStrategic or Co-development PartnerPrimary accreditation partner for Canadian family physicians. MDBriefCase courses are certified for Mainpro+ credits through CFPC and Quebec College of Family Physicians.
  • Royal Australian College of General Practitioners (RACGP)coreStrategic or Co-development PartnerAccreditation partner for Australian general practitioners. Courses are adapted and certified for Australian CME requirements.
  • Royal College of General Practitioners (RCGP) - UKcoreStrategic or Co-development PartnerUK-based accreditation partner for continuing professional development for general practitioners.
  • Queens UniversitymajorStrategic or Co-development PartnerAcademic partnership for medical education content development and review.
  • University of AlbertamajorStrategic or Co-development PartnerAcademic partnership for medical education content development.
  • University of ManitobamajorStrategic or Co-development PartnerAcademic partnership for medical education content development.
  • Sunnybrook Health Sciences CentremajorStrategic or Co-development PartnerAcademic hospital partnership for clinical content development and expert faculty.
  • Canadian Thoracic SocietymajorStrategic or Co-development PartnerProfessional society partnership for respiratory and pulmonary medicine content.
  • Obesity CanadamajorStrategic or Co-development PartnerPartnership for obesity management and metabolic health educational content.
  • Mental Health Commission of Canada (MHCC)majorStrategic or Co-development PartnerPartnership for mental health education and awareness content.
  • Saudi Food and Drug Authority (SFDA) / MOHcoreStrategic or Co-development PartnerHTA training programs for Saudi Arabian market, aligned with SFDA requirements for health technology assessment submissions.
  • Think ResearchcoreStrategic or Co-development PartnerParent company providing clinical decision support tools and connected ecosystem including RxBriefCase, Pharmapod, and OncologyEducation.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

MDBriefCase competitors and assessment

Company assessment

Direct peers

  • Medscape: WebMD-owned Medscape is the largest global digital CME provider for physicians, offering free accredited continuing education funded by pharma sponsorship — the same freemium, grant-monetized model that MDBriefCase operates.
  • Clinical Care Options: Clinical Care Options produces accredited CME/CE activities for physicians, pharmacists, and nurses funded by educational grants from pharma, overlapping directly with MDBriefCase's target audience and revenue model.
  • Pri-Med: Pri-Med provides free CME/CE for primary care clinicians through online and in-person channels, including pharma-supported programming — a directly comparable primary care-focused CME platform.
  • ProCE: ProCE is an accredited provider of continuing pharmacy education, directly comparable to MDBriefCase's RxBriefcase subsidiary for pharmacist-targeted accredited CE.
  • CE City: CE City provides accredited continuing education tracking and delivery for healthcare professionals, comparable to MDBriefCase's platform in serving the CE/CME credit accumulation workflow.
  • ACHL (Academy for Continued Healthcare Learning): ACHL is an ACCME-accredited provider of pharma-funded CME/CE across multiple therapeutic areas, competing with MDBriefCase for the same clinician audiences and pharma sponsorships.

Broad incumbents

  • HealthStream: HealthStream is a publicly traded healthcare workforce education and training company that addresses a related but broader enterprise compliance and clinical education market versus MDBriefCase's free, clinician-direct CME.
  • UpToDate: Wolters Kluwer's UpToDate is a clinical decision support and learning platform used by clinicians globally, adjacent to MDBriefCase's CME offering but broader in scope and primarily sold via institutional licenses rather than free, grant-funded CME.
  • DynaMed: EBSCO's DynaMed is a clinician reference and decision-support tool that competes for the same clinician mindshare as MDBriefCase's expert briefs and CME content, with a broader portfolio and institutional sales model.
  • Haymarket Media: Haymarket Media's medical division produces pharma-funded medical education, journals, and CME, comparable to MDBriefCase in its grant-funded clinician education model but operating at significantly greater scale across multiple global brands.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MDBriefCase social profiles

Digital presence

MDBriefCase compliance and trust

Trust signal

Compliance2 records

MDBriefCase financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MDBriefCase leadership team

Management profile

Number of profiles

MDBriefCase subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

MDBriefCase funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MDBriefCase M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MDBriefCase

What does MDBriefCase do?

MDBriefCase operates a digital continuing medical education (CME/CPD) platform that delivers free, accredited on-demand courses, live webinars, microlearnings, expert briefs, and clinical updates to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe. Content is developed with more than 30 global medical partner institutions and accredited through Mainpro+/CFPC, CCCEP, RACGP, RCGP, and other regional bodies. Revenue is generated through unrestricted pharmaceutical educational grants and newsletter sponsorships rather than user fees.

Is MDBriefCase a public or private company?

MDBriefCase is a private company. It is classified as corporate owned and is currently operating.

When was MDBriefCase founded?

MDBriefCase was founded in 2004. It employs 11 to 50 people.

Where is MDBriefCase based?

MDBriefCase is headquartered in Toronto, Canada, in the North America region.

How does MDBriefCase make money?

Two revenue lines are on record. Pharmaceutical Educational Grants are the primary driver. The others are advertising - Postcall Newsletter.

Who are MDBriefCase's main competitors?

Direct peers on record are Medscape, Clinical Care Options, Pri-Med, ProCE, CE City and ACHL (Academy for Continued Healthcare Learning). Broad incumbents are HealthStream, UpToDate, DynaMed and Haymarket Media.

Does MDBriefCase have an API?

No public API is recorded for MDBriefCase.

What industry is MDBriefCase in?

MDBriefCase's product category is Continuing Medical Education. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 5131 and its SIC code is 2741.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsMDBriefCase Acquires PostcallMDBriefCase, a Toronto-based interactive medical education provider, acquired Postcall, a physician newsletter service. The deal amount was not disclosed. The acquisition expands MDBriefCase's offerings, with Postcall serving doctors across Canada and the U.S.PR NewswireMDBriefCase Establishes World-Class Oncology Scientific Steering CommitteeMDBriefCase Group Inc., a global provider of online continuing medical education, announced the formation of an Oncology Education Scientific Steering Committee composed of global oncology thought leaders to advise on and implement oncology education programs worldwide. The committee, chaired by Dr. Scott Berry and including members from Canada, the UK, the USA, Switzerland, and Australia, will help align the company's educational content with the latest clinical advances. MDBriefCase and its subsidiary OncologyEducation were recently acquired by Think Research Corporation, a digital health company specializing in clinical knowledge-based software solutions.PR NewswireValeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin and Vitamin C for COVID-19Valeo Pharma issued a press release highlighting a MDBriefCase newsletter that compares Hesperidin to Vitamin C regarding potential therapeutic approaches for COVID-19. The company stated that scientific evidence suggests Hesperidin may interfere with SARS-CoV-2 viral entry and replication, while noting the newsletter found Vitamin C efficacy inconclusive.Tech Company NewsAn Interview With Jason Flowerday, CEO Of MDBriefCaseMDBriefCase, a Canadian online medical education provider, offers over 2,000 courses to 250,000+ members, delivering more than 2 million hours of accredited content. The company plans continued growth and innovation, focusing on tools to measure improved patient outcomes.PR NewswiremdBriefCase Group Inc. Appoints New CEO to Lead Global ExpansionmdBriefCase Group Inc. announced the appointment of Jason Flowerday as Chief Executive Officer, effective September 2018. Flowerday brings more than two decades of industry experience in operations management, business development, and strategy, having previously held CEO positions at healthcare and biotechnology companies and spent over a decade at Bayer Healthcare and Ortho Biotech. The company, which has delivered online accredited medical education since 2001 and currently serves over 170,000 members in 16 countries, indicated this appointment supports its ongoing global expansion strategy.PR NewswiremdBriefCase Group Inc. annonce le lancement de mdBriefCase Africa & Middle EastmdBriefCase Group launched its Africa and Middle East division on May 3, 2016, offering free accredited online continuing medical education. The program adapts its Canadian model to local health professionals' needs, with funding from companies like Pfizer, Sanofi, Bayer, and Sandoz.